Compounded GLP-1 drops or tablets vs injections: do the oral versions work?

This is a really important question, as the efficacy and safety of compounded GLP-1 oral versions are a frequent point of confusion.

Generally, no, compounded GLP-1 drops or tablets are highly unlikely to be effective, and there are significant concerns regarding their safety and quality.

Here's why:

1. The Science of Oral Absorption for Peptides:

   • GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) are peptides. Peptides are large, fragile molecules that are easily broken down by stomach acid and digestive enzymes when taken orally. This is why the vast majority of these medications are administered as injections.

2. The Exception: Rybelsus (FDA-Approved Oral Semaglutide):

   • The only FDA-approved oral GLP-1 medication is Rybelsus (semaglutide). It works because it uses a proprietary absorption enhancer called SNAC (salcaprozate sodium). SNAC protects the semaglutide from degradation in the stomach and helps it be absorbed into the bloodstream. This technology is unique to Rybelsus and is not easily replicated.

3. Problems with Compounded Oral GLP-1s:

   • Lack of Absorption Enhancer: Compounded oral versions typically lack the specialized absorption technology of Rybelsus. If you simply put semaglutide or tirzepatide powder into a capsule or liquid without this enhancer, it will almost certainly be destroyed by stomach acid before it can enter your system and have an effect.
   • Not FDA-Approved: Compounded medications are not approved by the FDA. This means they haven't undergone the rigorous testing for safety, efficacy, and consistent quality that commercial drugs like Ozempic, Wegovy, Mounjaro, Zepbound, and Rybelsus have.
   • Purity and Potency Concerns: There's no guarantee that compounded products contain the stated amount of the active ingredient, or that they are free from contaminants. The active ingredient itself (e.g., semaglutide) used by compounders might also be a different chemical form (like a salt, e.g., semaglutide sodium) than the FDA-approved base molecule, with unknown efficacy and safety.
   • Legal & Ethical Issues: The FDA has issued warnings about compounded GLP-1 products, especially those that are mass-produced or falsely marketed as generic versions of approved drugs.

Recommendation:

If you are considering GLP-1 therapy, your safest and most effective options are the FDA-approved medications:

• Injections: These are the gold standard for efficacy and have extensive clinical trial data.
  • Ozempic (semaglutide): Primarily for type 2 diabetes, often prescribed off-label for weight loss.
  • Wegovy (semaglutide): Specifically approved for weight management.
  • Mounjaro (tirzepatide): Primarily for type 2 diabetes, often prescribed off-label for weight loss.
  • Zepbound (tirzepatide): Specifically approved for weight management.
• Oral (If Injection is Not an Option):
  • Rybelsus (oral semaglutide): This is the only FDA-approved oral GLP-1. While effective, it generally has a lower maximum dose and is often considered less potent for weight loss compared to the injectable versions of semaglutide or tirzepatide.

Always consult with a qualified healthcare provider who can discuss the FDA-approved options with you, weigh the risks and benefits, and help you find the safest and most effective treatment plan for your specific needs.